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Abstract: The subclass B2 CphA (Carbapenemase hydrolysing Aeromonas) β-lactamase from Aeromonas 
hydrophila is a Zn
2+
 -containing enzyme that specifically hydrolyses carbapenems. In an effort to evaluate 

















), site-directed mutants of CphA were generated and characterized. 




, and thus is located in the 




 residues seem to be interacting with the second zinc ion, as their 
replacement by alanine residues has a negative effect on the affinity for this second metal ion. Val
67
 plays a 
significant role in the binding of biapenem and benzylpenicillin. The properties  of a  mutant with  a  five residue  
(LFKHV) insertion just after Val
67
 also reveals the importance of this region for substrate binding. This latter 
mutant has a higher affinity for the second zinc ion than wild-type CphA. The T157A mutant exhibits a 
significantly modified activity spectrum. Analysis of the K224Q and N116H/N220G/K224Q mutants suggests a 
significant role for Lys
224
 in the binding of substrate. Lys
226
 is not essential for the binding and hydrolysis of 
substrates. Thus the present paper helps to elucidate the position of the second zinc ion, which was controversial, 
and to identify residues important for substrate binding. 




In vivo, class B β-lactamases [1] require one or two zinc ions as enzymatic cofactors. By efficiently catalysing 
the hydrolysis of the β-lactam amide bond, these enzymes play a key role in bacterial resistance to this group of 
antibiotics. Several pathogens are now known to synthesize members of this class [2-7]. Metallo-β-lactamases 
exhibit very broad activity spectra [8]. Moreover, they are not susceptible to the common β-lactamase 
inactivators [9]. Presently, no clinically efficient inhibitor of metallo-β-lactamases has been found. The fact that 
some of the metallo-β -lactamase genes are plasmid-encoded represents an additional cause for concern [10,11]. 
On the basis of the known metallo-β-lactamase sequences, three different lineages, identified as subclasses B1, 














 in subclass B3) and 
His
263
 in subclasses B1 and B2. Each subclass thus possesses a different set of potential zinc ligands. 
The CphA (Carbapenemase hydrolysing Aeromonas) metallo-β -lactamase produced by Aeromonas hydrophila 
belongs to subclass B2, which is characterized by a uniquely narrow specificity profile. In contrast with metallo-
β-lactamases of subclasses Bl and B3, CphA efficiently hydrolyses only carbapenems and displays very poor 
activity against penicillins and cephalosporins [8,14], and exhibits maximum activity as a mono-zinc enzyme. 
The presence of a Zn
2+
 ion in a second low-affinity binding site noncompetitively inhibits the enzyme with a Ki 
value of 46 µM at pH 6.5 [15]. The structure of the mono-zinc CphA enzyme has been solved by X-ray 
crystallography [16]. Similarly to the known structures of metallo-β-lactamases of subclasses Bl [17-22] and B3 
[23,24], the X-ray structure of CphA reveals an αββα sandwich, with two central β-sheets and α-helices on the 
external faces. The active site is located at the bottom of the β -sheet core. In contrast with all reported structures 
                                                     
Abbreviations used: CphA, Carbapenemase hydrolysing Aeromonas; ESI, electrospray ionization; ICP-MS, inductively coupled plasma MS; 
LB, Luria-Bertani. 
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for the Bl and B3 subclasses, a long α3 helix (Arg140-Leu161) is located near the active-site groove of CphA. This 
α3 helix is a key element of the 'hydrophobic wall' which defines the active-site pocket. Thus whereas the 
enzymes of subclasses B1 and B3 exhibit a large cavity, the active site of CphA is very well defined and this 
explains the very narrow activity profile of the enzyme [16]. 
Contrary to the enzymes of subclasses Bl and B3, it was demonstrated that, in the subclass B2 CphA enzyme, a 
cysteine residue contributes to the first catalytic zinc-binding site [16,25-27]. This result suggested that the 
respective binding sites of the first and second zinc ions would be reversed in CphA compared with Bl and B3 
metallo-β-lactamases. However, on the basis of spectroscopic studies with another subclass B2 enzyme (ImiS), 






Furthermore, by soaking CphA crystals in a biapenem solution, a reaction intermediate could be trapped into the 
active site of the enzyme [16]. The analysis of this structure allowed us to select several residues potentially 








 (Figure 1). 
The side chain of Val
67
 is in van der Waals contact with the 1β-methyl group of biapenem. Val67 is a residue of 




) [13,16] and is part of the 'hydrophobic wall' which defines the active site of CphA. The 
Val
67
 residue is conserved in the B2 subclass metallo-β-lactamases and in the BcII, CcrA and IMP-1 Bl subclass 
enzymes [13]. The hydroxyl group of Thr
157
 forms hydrogen bonds with the hydroxyethyl group on C-6 of 
biapenem and, after hydrolysis, with the newly formed carboxylate group [16]. Thr
157, a residue of the α3 helix 
located near the active-site groove, is only conserved in subclass B2 enzymes. As in CcrA and IMP-1 subclass 
Bl enzymes [21,30-33], the side chain of Lys
224 
forms an electrostatic interaction with the invariant carboxylate 
group on C-3 of β-lactam. It is conserved in subclass B2 and B1 enzymes, with the exception of VIM-2 [13]. The 
Lys
226
 side chain is the only charged side chain near the C-2 bicyclotriazoliumthio group of biapenem. 
Figure 1 : Structure of biapenem (a), the reaction intermediate (b) and view of the active site of CphA in 
complex with the reaction intermediate (c) 
 
In order to evaluate their importance in metal binding and/or catalysis, substitutions of residues potentially 
involved in zinc binding have been performed by site-directed mutagenesis (H118A, D120A, D120T, H196A 
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and H263A). To examine the effects of the charge or size of the residues on the substrate specificity, Val
67
 was 
replaced by an alanine, isoleucine or aspartic acid residue, Thr
157







 was also replaced by a glutamine residue in the Nl 16H/N220G extended-spectrum 
double mutant [34]. 
EXPERIMENTAL 
Bacterial strains and vectors 
Escherichia coli DH5α (Stratagene) and E. coli BL21 (DE3) pLysS Star (Invitrogen) strains were used as hosts 
for the construction of the different expression vectors and for the production of β-lactamases respectively. 
pET9a-CphA [35] was used as the plasmid template for PCR site-directed mutagenesis amplifications. The 
pK18-CphA vector was constructed by ligation of the EcoRI/SmaI excised fragment of pAS20R [4] and the 
SmaI/ HindIII excised fragment of pET9a-CphA [35] into the polylinker of the pK18 vector at the EcoRI and 
HindIII sites [36]. Moreover, a unique PstI restriction site was introduced by site-directed mutagenesis at the end 
of the signal-peptide coding sequence. The CphAPstIa and CphAPstIb primers used for this purpose are 
described in Supplementary Table S1 (at http://www. BiochemJ.org/bj/414/bj4140151add.htm). pK18-CphA 
was then used as the DNA template in the pentapeptide scanning reaction [37] described below. 
Chemicals and antibiotics 
The primers used for the mutagenesis were synthesized by Eurogentec (Liège, Belgium). Kanamycin was 




) was from Merck Sharp and Dohme and biapenem 




) was from Shionogi Pharmaceutical (Osaka, Japan). Ampicillin, benzylpenicillin (∆ε235 

















) from Unipath Oxoid (Basingstoke, U.K.). The 
variations of the molar extinction coefficients on β-lactam hydrolysis are from references [38] (biapenem) and 
[39]. The antibiotics used in this study are illustrated in Figure 1 (biapenem) and Supplementary Figure S1 (at 
http://www.BiochemJ. org/bj/414/bj414015 ladd.htm). 
Site-directed mutagenesis 
The QuikChange® site-directed mutagenesis kit (Stratagene) was used to generate all the mutations. The primers 
designed for these experiments are listed in Supplementary Table S1. The mutants were constructed using 
pET9a-CphA WT (where WT is wild-type) as the DNA template. The triple mutant N116H/N220G/ K224Q was 
constructed using the pET9a-Nl 16H-N220G mutant construct [34] as the template DNA. The introduction of the 
desired mutations and the absence of additional unwanted mutations were always verified by DNA sequence 
analysis. 
Pentapeptide scanning 
A pentapeptide-scanning reaction [37] was performed with the help of the GPS™-LS scanning system (New 
England Biolabs). This system allows the insertion of 15 bp linkers at random positions throughout the blaCphA 
gene on the pK8-CphA plasmid. The different plasmids were used to transform E. coli DH5α by electroporation. 
The colonies were selected on LB (Luria-Bertani) agar plates supplemented with 50 µg/ml kanamycin and 10 
µg/ml imipenem, and 50 µg/ml kanamycin and 8 µg/ml benzylpenicillin respectively. The plasmids were 
prepared and the different blaCphA genes were DNA sequenced in order to determine the position of the 
insertion. 
Protein expression and purification 
The genes encoding the mutant proteins were cloned into pET9a using the BamHI and NdeI restriction sites. The 
different vectors were then introduced into E. coli strain BL21 (DE3) pLysS Star. Overexpression and 
purification of mutant proteins was performed as described previously for the wild-type protein [15,27,35] with 
the following modification. Bacteria expressing the wild-type protein were grown for 8 h at 37 °C in 2YT 
medium, whereas those expressing the mutant proteins were grown for 24 h at 18 °C in the same medium. 
Growth at this reduced temperature was made necessary by the fact that the mutant proteins were produced 
mainly in a non-soluble form (inclusion bodies) when the cultures were grown at 37 °C. 
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ESI (electrospray ionization)-MS and metal content determination 
Samples of wild-type and mutant CphA enzymes were equilibrated in 10 mM ammonium acetate buffer (pH 6.5) 
by centrifugal filtration prior to ESI-MS. For each protein, mass spectra were obtained under both denaturing 
and native conditions. Denaturation of the protein was performed by dilution of the protein to a final 
concentration of 2-5 µM in 1:1 (v/v) water/acetonitrile containing 0.1 % formic acid. The native protein was 
diluted to 10-15 µM in 10 mM ammonium acetate buffer. 
All mass spectra were acquired on a Q-TOF1 mass spectrometer (Micromass) equipped with a nano ESI source 
using Au/Pd-coated borosilicate needles purchased from Protana (Odense, Denmark). Capillary voltage was set 
at 1250 V and cone voltage at 40 V and 60 V for the denatured and native proteins respectively. Acquisition time 
was 3 to 5 min across an m/z range of 400-3000. The mass spectra were processed with MassLynx v3.1 software 
(Micromass). The instrument was calibrated using a mixture of myoglobin and trypsinogen. The zinc content of 
each protein was derived from the mass difference between the native and denatured proteins. 
Determination of the zinc content using ICP-MS (inductively coupled plasma MS) 
Protein samples were dialysed against 15 mM sodium cacodylate (pH 6.5). Protein concentrations were 




). The zinc content was determined by 
ICP-MS as described previously [15, 27]. 
Stability toward chaotropic agents 
The stability of the different proteins was studied by fluorescence. The wild-type and mutant enzymes (0.05 
mg/ml) were incubated for 16 h in the presence of increasing urea concentrations (0-8 M) at 4 °C. Fluorescence 
emission spectra of the enzymes were recorded at 20 °C with a PerkinElmer LS50B luminescence spectrometer 
using excitation and emission wavelengths of 280 and 333 nm respectively. 
CD 
CD spectra of the different enzymes (0.5 mg/ml) were obtained using a JASCO J-810 spectropolarimeter. The 
spectra were scanned at 20 °C from 200 to 250 nm (far-UV) and from 250 to 310 nm (near-UV) with 1 nm steps. 
Determination of kinetic parameters 
Hydrolysis of the antibiotics was monitored by following the absorbance variation resulting from the opening of 
the β -lactam ring, using a Uvikon 860 spectrophotometer equipped with thermostatically controlled cells and 
connected to a microcomputer. For biapenem, imipenem, benzylpenicillin, nitrocefin, cephaloridine and 
cefotaxime, the wavelengths measured were 294, 300, 235, 482, 260 and 260 nm respectively. Cells with 0.2-1.0 
cm pathlengths were used, depending on the substrate concentrations. When the Km values of the studied 
enzymes were sufficiently high, the kcat and Km parameters were determined either under initial-rate conditions, 
using the Hanes linearization of the Henri-Michaelis-Menten equation, or by analysing the complete hydrolysis 
time courses [40]. Low and very high Km values were determined as Ki values using imipenem or nitrocefin as 
reporter substrates. In the cases of low Km values, the kcat values were obtained from the initial hydrolysis rates 
measured at saturating substrate concentration and, in the cases of high Km values, kcat was derived from the 
kcat/Km ratio. All experiments were performed at 30 °C in 15 mM sodium cacodylate (pH 6.5). 
Inactivation by EDTA 
Inactivation of CphA wild-type and the H118A, H196A, H263A and D120A mutants by EDTA was studied in 
15 mM sodium cacodylate (pH 6.5) at 30 °C in the presence of different concentrations of EDTA in a total 
volume of 0.5 ml. Imipenem (200 µM) was used as the reporter substrate. Since the inactivation time courses 
followed pseudo-first-order kinetics, the rate constants characterizing the inactivation of the enzyme were 
calculated from the dependence of the pseudo-first-order constant Ki on the chelating agent concentration on the 
basis of the following model: 
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where C is the chelator, E is the apoenzyme, E.Zn is the metalloenzyme, E.Zn.C is a ternary metalloenzyme-
chelator complex, k+2 is the individual rate constant for the dissociation of E.Zn.C into E + Zn.C, k-2 is the 
association constant, which was negligible in the case of the H263A mutant, K is the dissociation constant of the 
E.Zn.C ternary complex and Zn.C is the metal-chelator complex. 
As [Zn.C] is higher than [E], the ternary complex formation from the apoenzyme and the zinc-chelator complex 
is characterized by a pseudo-first-order constant: k-2' = k-2[Zn.C]. 
The individual values of K and k+2 were determined by fitting the values of Ki to eqn (1): 
 
where [S] and Km were the concentration and the Km value of the reporter substrate respectively. 
 
Enzymatic measurement in the presence of increasing concentrations of zinc and determination of Kd2 
Residual activity in the presence of increasing concentrations of zinc was measured at 30 °C in 15 mM sodium 
cacodylate (pH 6.5) as already described [27]. When binding of the second zinc ion resulted in a complete loss of 
activity, the data were analysed according to eqn (2) [27]: 
 
where RA is the residual activity and Kd2 is the dissociation constant for the second zinc ion. 
When binding of the second zinc ion resulted in an incomplete loss of activity or in an increase of activity, the 
following equation was used [27]: 
 
where a is the ratio of activity at saturating zinc concentration {[Zn](∞)} compared with activity in the absence of 
added zinc {[Zn](0)}{activity [Zn](∞)/activity [Zn](0)}. 
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Table 1: Masses and metal binding for CphA wild-type and mutant constructs measured under native and 
denatured conditions. The average mass of a Zn
2+
 ion is 65.4 Da. However, two or more protons can be 
displaced on protein binding, giving the bound Zn
2+
 ion an apparent mass of 63.4 Da. 
Protein Assay 
conditions 
Calculated mass (Da) Measured mass (Da) Mass difference (Da) Number of Zn2+ 
ions 
Wild-type Native - 25253.5 63.9  
 Denatured 25189 25189.6 - - 
H118A Native - 25187.6 62.8  
 Denatured 25123 25124.8 - - 
D120A Native - 25206.7 61.6  
 Denatured 25146 25145.1 - - 
D120T Native - 25237.3 62.2  
 Denatured 25176 25175.1 - - 
H196A Native - 25187.6 62.9  
 Denatured 25123 25124.7 - - 
H263A Native - 25218.5 62.7  
 Denatured 25123 25122.4 - - 
V67A Native - 25223.3 62.9  
 Denatured 25161 25160.4 - - 
V67I Native - 25265.1 60.8  
 Denatured 25203 25204.3 - - 
V67D Native - 25266.9 62.1  
 Denatured 25205 25204.8 - - 
V67LFKHV Native - 25874.8 62.4 1 (70%) 
 Native - 25936.3 123.9 2 (30%) 
 Denatured 25904(25815)* 25812.4 - - 
T157A Native - 25221.7 63.3  
 Denatured 25159 25158.4 - - 
K224Q Native - 25251.8 61.7  
 Denatured 25189 25190.1 - - 
K226Q Native - 25252.5 63.7  
 Denatured 25189 25188.8 - - 
N116H/R121H/K224Q Native - 25218.8 62.7  
 Denatured 25155 25156.1 - - 
*The value in parentheses is obtained by assuming the elimination of the C-terminal serine residue. 
RESULTS AND DISCUSSION 
A mutant protein containing an LFKHV insertion located just after Val
67
 (hereafter referred to as V67LFKHV) was 
obtained by a pentapeptide-scanning experiment. The E. coli DH5α cells transformed by pK18-CphA V67LFKHV 
were unable to grow on LB agar plates supplemented with 10 µg/ml imipenem, in contrast with bacteria 
producing the wild-type enzyme. These cells were also unable to grow in the presence of 8 µg/ml ampicillin. The 
V67LFKHV mutant was produced in the periplasmic fraction of E. coli DH5α (result not shown). 
The different mutants were expressed in E. coli BL21 (DE3) pLysS Star and purified to homogeneity. The 
presence of the mutations was verified by MS (Table 1). Within experimental errors, the mutants were found to 
exhibit the expected masses, with the exception of the V67LFKHV mutant, which presented a mass deficit of 92 
Da. The N-terminal sequence of this mutant showed that there is no amino acid loss at the N-terminal side. The 
difference between the calculated and measured masses could thus be due to the loss of the C-terminal serine. 
The stability of the different mutants in the presence of a denaturating agent (urea) was similar to that of the 
wild-type enzyme (C1/2 = 2.7-3 M) except for the T157A mutant (C1/2 = 2.2 M) and the H263A mutant (C1/2 = 
2.4 M), which were a little less stable. 
All the mutant constructs had far-UV CD spectra which were superimposable on that of wild-type CphA (results 
not shown). The tertiary structures were conserved for the H118A and H196A mutant constructs, whereas the 
environment of one or more aromatic residues was modified in the H263A, D120A and D120T mutant 
constructs when compared with the wild-type enzyme (see Supplementary Figure S2 at 
http://www.BiochemJ.org/bj/414/ bj4140151add.htm). Near-UV CD spectra and fluorescence emission spectra 
of the N116H/N220G/K224Q and V67LFKHV mutant constructs suggested a small conformation change occurred 
in the protein tertiary structure (results not shown). Such a small conformational change had already been 
observed for the N116H/ N220G double mutant [34]. 
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The activities of the mutants were measured against several compounds representing the three major families of 
β-lactam antibiotics, namely carbapenems, penicillins and cephalosporins, in the absence of added zinc (free zinc 
concentrations below 0.4 µM) (Tables 2 and 3). Under these conditions, all the mutant constructs, except 
V67LFKHV, were shown to contain one zinc ion, as does the wild-type enzyme (Tables 1 and 4). V67LFKHV already 
exhibited a di-zinc form (30 %) in conditions where the wild-type enzyme only co-ordinates a single zinc ion 
(Table 1). 





 are not involved in the binding of the catalytic metal ion [16], their replacement by 
alanine residues drastically reduces the enzymatic activity, suggesting important roles for these residues in the 
catalytic mechanism. The H118A and H196A mutations lead to a decrease of at least 1000-fold in activity 
against carbapenems compared with the wild-type enzyme (Table 2). This result is perfectly in agreement with 
the structural data. Garau et al. [16] suggested that His
118
 is the general base which activates the hydrolytic water 
molecule and that His
196
 contributes to the oxyanion hole by forming a hydrogen bond with the carbonyl oxygen 
of the β-lactam bond. Moreover, these residues might stabilize the carboxylate which is formed on hydrolysis of 




contrasts with the results obtained for Asn
116
, which in 
subclass B2 enzymes replaces His
116
, one of the zinc ligands for enzymes in subclasses B1 and B3. Indeed, 
whereas the H116S substitution reduces the activity of the subclass B1 Bacillus cereus enzyme 15-20-fold, the 
N116S substitution in CphA yielded an enzyme whose catalytic and zinc-binding properties were similar to 
those of the wild-type enzyme. These results indicate that Asn
116
 in subclass B2 enzymes is not a 'functional 
substitute' for His
116 
in subclasses Bl and B3 [27]. 
Table 2: Kinetic parameters of the wild-type CphA enzyme and the H118A, H196A, H263A, D120A and D120T 
mutant constructs. Measurements were taken at 30°C in 15 mM sodium cacodylate (pH 6.5). Values for the wild-
type enzyme are from Vanhove et al. [27]. S.D. values (not shown) were below 10%. N.D., not determined. 
Enzyme Substrate kcat (s
-1





Wild-type Imipenem 1200 340 3500000 
 Biapenem 300 170 1800000 
 Benzylpenicillin 0.03 870 35 
 Nitrocefin 0.008 1300 6 
 Cephaloridine < 0.006 6000 <1 
H118A Imipenem 2.4 1150 2100 
 Biapenem 0.1 730 150 
 Benzylpenicillin 0.007 210 33 
 Nitrocefin 0.005 30 170 
 Cephaloridine >0.01 >4500 2.2 
H196A Imipenem 16 4300 3700 
 Biapenem N.D. N.D. N.D. 
 Benzylpenicillin >0.1 >5000 20 
 Nitrocefin 0.006 15 400 
 Cephaloridine > 0.11 >4500 24 
H263A Imipenem 0.02 1700 12 
 Biapenem > 0.005 >1500 3 
 Benzylpenicillin N.D. N.D. N.D. 
 Nitrocefin 0.003 15 200 
 Cephaloridine N.D. N.D. N.D. 
D120A Imipenem 0.024 330 73 
 Biapenem 0.0015 100 15 
 Benzylpenicillin N.D. N.D. N.D. 
 Nitrocefin 0.0024 26 92 
 Cephaloridine N.D. N.D. N.D. 
D120T Imipenem 0.025 210 120 
 Biapenem N.D. N.D. N.D. 
 Benzylpenicillin N.D. N.D. N.D. 
 Nitrocefin 0.0002 50 4 
 Cephaloridine N.D. N.D. N.D. 
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 by residues which cannot serve as zinc ligands, the mutant proteins could 
still bind one zinc ion, but were also catalytically impaired in a dramatic manner. The D120A, D120T and 
H263A mutations resulted in a very large decrease in the activities against carbapenems (at least 50000-fold), 
mainly due to strongly decreased kcat values (Table 2). This very low residual activity could be explained by a 
poor positioning of the Zn
2+
 ion in the active site of the mutants and a deformation of its co-ordination sphere. In 
this respect, it is interesting to note that the N220G mutation, which does not directly affect any of the zinc 
ligands but is situated next to Cys
221
, causes a displacement of the latter in 20% of the molecules [16]. 
ICP-MS shows that, in contrast with the wild-type enzyme, these five mutant enzymes remain in their mono-zinc 
forms even in the presence of 100 µM free zinc (Table 4). 
The effect of the zinc ion concentration on enzyme activity has also been studied. The binding of the second zinc 
ion is severely affected by the H118 A and H196A mutations (Figure 2a). From these curves, the H118A and 
H196A mutants are found to exhibit much higher Kd2 values (940 ± 80 and 1250 ± 50 µM respectively) than the 
wild-type enzyme (46 ± 3 µM). The poorer binding of the second zinc ion by CphA H118A was also 
demonstrated by MS, which failed to detect the di-zinc form of this mutant [41]. This indicates that both 
histidine residues are involved in the binding of the second, inhibitory, zinc ion. 
This interpretation is in disagreement with the conclusions of Crowder and co-workers that the inhibitory zinc 
ion binds at a distance of at least 0.5 nm from the catalytic one in the ImiS subclass B2 enzyme [28]. Our results 
could be reconciled with this hypothesis if both of our mutations resulted in significant conformational changes. 
On the basis of the CD data (Supplementary Figure S2), this does not seem to be the case. Crowder and co-
workers have shown that the inhibitory zinc ion is bound by a sulphur atom [29]. The sulphur ligand in the 
inhibitory site should come from a methionine residue, since the only cysteine residue (Cys
221
) is a ligand of the 
first zinc ion. The mutation of Met
146
 to an isoleucine residue abolishes metal inhibition. However, mutation of 
other CphA residues, which have not been implicated as ligands of the second zinc ion, can have similar effects 
(lower inhibition or even activation by an excess of zinc, as observed below). Moreover, a careful examination of 




are poorly positioned to bind the same zinc 
ion. The distance between their Cα groups is 7.57 Å (1 Å = 0.1 nm), whereas the distances between the sulphur 
atom of Met
146
 and the nitrogen atoms of the imidazole group of His
118
 are 10.40 and 10.91 Å respectively. Also, 
the space between these residues does not allow the accommodation of a zinc ion because it is occupied by the 




 loop connecting strand β6 and helix α2. 




 in the binding of the inhibitory zinc ion makes sense in the light 
of the strongly decreased activity of the mutants (Table 2), since this binding would prevent them from playing 
their catalytic roles in the hydrolysis of carbapenems. 












. This second zinc ion would approximately be located at a position similar to that of the first 
zinc ion in subclasses B1 and B3 β-lactamases and two of the zinc ligands would be conserved. Compared with 
the available structure of CphA, the only modification needed would be a 180° rotation around the Cβ-Cγ bond 
of the His
196
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Table 3: Kinetic parameters of the CphA wild-type, V67A, V67I, V67D, V67LFKHV, T157A, K224Q, K226Q, 
N116H/N220G and N116H/N220G/K224Q mutant enzymes. Measurements were performed at 30°C in 15 mM 
sodium cacodylate (pH 6.5). Values for the wild-type enzyme are from Vanhove et al. [27] and values for the 
N116H/N220G double mutant are from Bebrone et al. [34]. S.D. values (not shown) are below 10%. 
Enzyme Antibiotics kcat (s
-1





Wild-type Imipenem 1200 340 3500000 
 Biapenem 300 170 1800000 
 Benzylpenicillin 0.03 870 35 
 Nitrocefin 0.008 1300 6 
 Cefotaxime > 0.0002 >100 2 
V67A Imipenem 1000 220 4500000 
 Biapenem 100 100 1000000 
 Benzylpenicillin 0.004 1000 4 
 Nitrocefin 0.005 26 180 
V67I Imipenem 1770 180 9000000 
 Biapenem >50 >1500 33000 
 Benzylpenicillin 0.08 730 110 
 Nitrocefin 0.004 50 80 
V67D Imipenem 1280 310 4000000 
 Biapenem >100 >1500 66000 
 Benzylpenicillin >0.03 >5000 6 
 Nitrocefin 0.004 36 110 
V67LFKHV Imipenem >30 >1500 20000 
 Biapenem >2.4 >1500 1600 
 Nitrocefin > 0.006 >2000 3 
T157A Imipenem 1680 570 3000000 
 Biapenem >130 >1500 87000 
 Benzylpenicillin 1 550 1950 
 Nitrocefin 0.015 110 140 
 Cefotaxime 0.023 450 50 
K224Q Imipenem >490 >1500 330000 
 Biapenem >60 >1500 40000 
 Benzylpenicillin >0.03 >5000 6 
 Nitrocefin 0.007 135 52 
 Cephaloridine 0.024 1000 24 
 Cefotaxime 0.001 700 1.4 
K226Q Imipenem 1000 380 2600000 
 Biapenem 1000 840 1200000 
 Benzylpenicillin 0.004 800 5 
 Nitrocefin 0.01 850 12 
 Cephaloridine 0.006 1700 3.5 
 Cefotaxime 0.0006 140 4.3 
N116H/N220G Imipenem 16 185 86000 
 Biapenem 5 100 50000 
 Benzylpenicillin 3.3 150 22000 
 Nitrocefin 0.7 4 180000 
 Cephaloridine 0.9 145 6200 
 Cefotaxime 0.3 50 6000 
N116H/N220G/K224Q Imipenem 0.9 300 3000 
 Biapenem 0.26 390 670 
 Benzylpenicillin 0.13 920 140 
 Nitrocefin 0.2 32 6000 
 Cephaloridine 0.03 53 570 
 Cefotaxime 0.015 434 34 
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Table 4: Summary of zinc binding for CphAwild-type and the H118A, H196A, H263A, D120A and D120T 
mutants. S.D. values (not shown) were below 10%. N.D., not determined. 
 [Zn
2+
]≤ 0.4µM [Zn2+] = 100µM 
Protein MS ICP-MS MS ICP-MS 
Wild-type 1 1.0 2 1.9 
H118A 1 0.9 N.D. 1.2 
H196A 1 N.D. N.D. 1.2 
H263A 1 1.0 N.D. 0.9 
D120A 1 1.3 N.D. 1.3 
D120T 1 1.3 N.D. 1.3 
From this crude modelling, the identity of the third ligand of the second zinc ion is not clear. However, the fact 
that Cys
221 





of the first zinc-binding site retain relatively high affinities for zinc (Kd < 0.4 µM) points towards a role of Cys
221
 
in the binding of both zinc ions. The role of a cysteine residue in the simultaneous binding of two zinc ions is a 
known feature that has been observed previously; for example, in the structure of the DNA-binding domain of 
the Gal4 transcription factor [42]. The second zinc-binding site described here would probably be more 
energetically favourable (one side chain rotation) than the major rearrangement required to organize a zinc-
binding site involving the embedded Met
146
 residue. The presence of a sulphur atom in the second binding site 
that resulted in the identification of Met
146
 could maybe be explained by the involvement of Cys
221
 in the binding 
of both ions. 
 
Figure 2: Percentage residual activity measured in the presence of increasing concentrations of zinc.  
(a) CphA wild-type (WT, •) and the H118A (A) and H196A (■) mutants activity on imipenem. The curves are the 
best fits determined using eqn (2). (b) CphA WT (•) and the D120A (∆), D120T (□) and H263A (♦) mutants 
activity on imipenem. The curves are the best fits determined using eqn (2). All experiments were performed at 
30°C in 15 mM sodium cacodylate (pH 6.5) with a substrate concentration of 100 µU. S.D. values (not shown) 
are below 10%. 
 
Published in: Biochemical Journal (2008), vol. 414, iss.1, pp.151-159 
Status: Posprint (Author’s version) 




 mutant constructs are nonetheless probably decreased when compared 
with that of the wild-type enzyme, as indicated by higher rates of inactivation by EDTA (Table 5). The rates of 
inactivation are probably between those observed for site 1 and site 2 in the wild-type enzyme, for which the Kdl 
is below 10 pM [43] and Kd2 is 46 µM [15]. Because the residual activity of these mutants can be inhibited by 
EDTA and because the Kd2' values deduced from the inhibition by zinc are still relatively close to 46 µM (Figure 
2b) {Kd2 values arel5±1.5µMforH263Aand44±6and41±2µMforD120A and D120T mutants respectively), the 
binding of the first zinc ion to these mutants might result from a reduced affinity for site 1 rather than an 
improved affinity for the inhibitory site 2. The occupation of both sites at the same time has not been observed 
[41]. 
Mutational analysis of putative substrate-binding-site residues 
Our kinetic results are in good agreement with the crystallographic structure of CphA in complex with biapenem 
[16] and confirm the importance of the Val
67
 residue for the binding of this substrate into the active site of CphA. 
The Km values of the V67I and V67D mutants for biapenem strongly increase in comparison with wild-type 
CphA, so that only kcat/Km could be measured (Table 3). This phenomenon could be due to a less favourable 
interaction with the 1β-methyl group of the antibiotic. In addition, we show that a hydrophobic interaction 
between Val
67
 and the C-2 methyl groups of penicillin is likely, since the Km value of the V67D mutant construct 
for benzylpenicillin is larger than that of the wild-type CphA enzyme (Table 3). A similar interaction has already 
been proposed between the BcII subclass B1 enzyme and benzylpenicillin [44]. Moreover, Simona et al. [45] 




) in the mechanism of binding carbapenem 
molecules. 
Figure 3: Representation of the active site of the CphA enzyme. 
(a) Structure of the mono-zinc active site (PDB code 1X8G). (b) Model of a di-zinc active site with addition of a 
zinc ion and rotation of the His
196
 side chain, the only modification when compared with (a). The dashed lines 
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Table 5: Individual parameters for the inactivation of CphA wild-type, H118A, H196A, H263A and D120A 












5.5 0.007 0.0014 1.3 
H118A 5.2 0.002 0.003 0.4 
H196A 16.4 0.008 0.005 0.5 
H263A 0.01 0.005 - 500 
D120A 0.5 0.003 0.00001 6 
As for wild-type CphA [15], the binding of a second zinc ion inhibits the hydrolysis of imipenem by the Val
67
 
mutants in a noncompetitive manner. The dissociation constants for the second zinc ion are similar to that of the 
wild-type enzyme for the V67I and V67D mutants (46 ± 3 µM) or slightly reduced for the V67A mutant (16 + 3 
µM). 
The V67LFKHV mutant, with a five-residue insertion just after Val
67
, displays a strongly decreased affinity for 
biapenem, imipenem and nitrocefin (Table 3). The extended loop might fold above the active-site groove and in 
this way reduce the accessibility of the active site. The lengthening of the L1 loop and/or the introduction of a 
charged residue (lysine) could have a negative effect on the affinity of the enzyme for its substrate. The apparent 
dissociation constant for the second zinc ion is below 1 µM, whereas it is 46 µM for wild-type CphA. Together 
with the fact that this mutant exhibits a di-zinc form (30 %) under conditions where the wild-type enzyme is only 
mono-zinc, this result suggests that the histidine residue in the inserted pentapep-tide might probably interact 







However, a significant rearrangement would be necessary in order to bring the additional histidine residue into 




. Consequently, this hypothesis should be confirmed by EXAFS 
and PAC (perturbed angular correlation) experiments and by resolution of the three-dimensional structure. 
Various modifications can broaden the activity spectrum of the strict CphA carbapenemase. The N116H/N220G 
extended-spectrum mutant was obtained by a site-directed approach on the basis of sequence alignments between 
members of the B2 and B1 subclasses [34]. In the present paper, surprisingly, the replacement of Thr
157
 with an 
alanine residue results in a significant modification of the activity spectrum of the enzyme, since the catalytic 
efficiency of this mutant towards benzylpenicillin, cefotaxime and nitrocefin is larger than that of the wild-type 
enzyme. However, although the T157A mutant is far from being as efficient as the N116H/N220G mutant [34], 
it retains, in contrast, strong activity towards imipenem (Table 3). 
Thr
157
 does not seem to play an important role in the CphA catalytic mechanism, but according to the structure of 
CphA in complex with modified biapenem (PDB code 1X81) and the proposed mechanism for enzymatic 
activity on carbapenems [16], the C-6 (C-7 for cephalosporins) side chains of β-lactam antibiotics are likely to be 
located in the environment of Thr
157
 during hydrolysis. A residue with a slightly reduced bulkiness could 
therefore be more suited to accommodate the larger and differently oriented side chain of most β-lactam 
antibiotics compared with carbapenems. This could explain the more extended spectrum observed for this 
mutant. Because the T157A mutant only retains a good activity against imipenem whereas the interactions of 
imipenem and biapenem with Thr
157
 should be affected similarly, we believe that this residue is more important 
for optimum positioning of the substrate than for its affinity for the active site. The bulkier and more rigid 
biapenem would therefore need extra anchoring to be perfectly oriented, whereas imipenem would fit more 
naturally into the active site. 
Zinc ions inhibit the hydrolysis of imipenem and benzylpenicillin by the T157A mutant in a non-competitive 
manner, but the di-zinc form of this mutant retains 40 % activity towards benzylpenicillin, whereas it is 
practically completely deprived of activity towards imipenem (Figure 4a). The dissociation constants for the 
second zinc ion are similar for both substrates and similar to that of the wild-type enzyme (46 ± 3 µM for T157A 
and imipenem, 55 ± 11 µM for T157A and benzylpenicillin and 46 ± 3 µM for the wild-type enzyme and 
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Figure 4: Percentage residual (or relative) activity measured in the presence of increasing concentrations of 
zinc. (a)  T157A mutant construct incubated with imipenem and benzylpenicillin. The curves are the best fits 
determined using eqn (2) (●, imipenem) or eqn (3) (A, benzylpenicillin). 
(b)  N116H/N220G/K224Q triple mutant incubated with imipenem and nitrocefin. The curves are the best fits 
determined using eqn 3 (●, imipenem; ■ nitrocefin). All experiments were performed at 30°C in 15 mM sodium 
cacodylate (pH 6.5). The substrate concentrations were 100 µM for imipenem, 1 mM for benzylpenicillin and 
100 µM for nitrocefin. S.D. values (not shown) are below 10%. 
 
In contrast with the N116H/N220G mutant [34], imipenem and benzylpenicillin seem in this case to be 
hydrolysed via the same mechanism. The activity of wild-type CphA against benzylpenicillin is too low to allow 
meaningful measurements to be obtained; however, zinc also behaves as an inhibitor in this case.  
Our kinetic results show that Lys
224
 is important for the binding of β-lactam antibiotics into the active site of 
CphA, as already observed for the subclass B1 enzymes CcrA and IMP-1 [21,30-33]. The K224Q mutant 
exhibits a decreased catalytic efficiency towards carbapenem substrates when compared with the wild-type 
enzyme. The individual kcat and Km values could not be determined. In the same way, the Km value for 
benzylpenicillin is strongly increased (Table 3). This role is in good agreement with the crystallographic 
structure of CphA in complex with biapenem, which shows an electrostatic interaction between Lys
224
 and the 
invariant C-3 carboxylate of the β-lactam antibiotic, and with the simulations of Xu et al. [46]. 
The N116H/N220G/K224Q triple mutant presents increased Km values and decreased kcat values when compared 
with the Nl16H/N220G double mutant (Table 3). This triple mutant, while significantly less active than the 
N116H/N220G double mutant, retains a relatively extended spectrum when compared with the wild-type 
enzyme. It is particularly interesting since, as already observed for the N116H/R121H/N220G triple mutant [34] 
and in contrast with the wild-type enzyme, added zinc acts as an activator. The hydrolysis rate of imipenem and 
nitrocefin by the N116H/N220G/K224Q triple mutant strikingly increases to 1.6- and 2.5-fold respectively at 
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saturating Zn
2+
 concentrations (Figure 4b). The dissociation constant for the second zinc ion determined for this 
triple mutant (4.0 ± 1.1 µM and 1.6 ± 0.2 µM with imipenem and nitrocefin respectively as substrates) is similar 
to that of the Nl 16H/N220G double mutant (5.0 ± 0.9 µM [34]). For all of the other mutants, the hydrolysis of 
nitrocefin is independent of the concentration of zinc. 
This phenomenon remains difficult to explain in the absence of structural data on the di-zinc-inhibited form of 
the wild-type enzyme, but it is quite likely that binding of the second zinc ion induces distinct structural changes 
in both the wild-type and mutant proteins. 
The replacement of Lys
226
 only affects the kinetic parameters of biapenem. Although the kcat value is increased, 
the catalytic efficiency remains similar to that of the wild-type enzyme. The K226Q mutation does not 
significantly modify the affinity for the second zinc ion (Kd2 = 85±10µM). 
Conclusion 




 participate in the catalytic mechanism of the subclass B2 CphA 
metallo-β-lactamase, for which an intact Asp120/Cys221/His263 site is essential. The position of the second 
inhibitory zinc ion has not been identified with certainty, but it is likely to be equivalent to the 'histidine' site 




 are involved in the binding of this second zinc ion 
and Cys
221





 could play a role also. 






 residues for carbapenem binding into the 
active site of CphA. 
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Figure S1: Structures of the β-lactam antibiotics used in this study. 
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Figure S2:   Near-UV CD spectra. The protein concentrations were 0.5 mg/ml in all cases. (a) Wild-type CphA 
enzyme (solid line) and the H118A (dashed line) and H196A (dotted line) mutant constructs. (b) Wild-type CphA 
enzyme (solid line) and the D120A (dashed line), D120T (dotted line) and H263A (dashed and dotted line) 
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Table S1: List of mutagenic primers used for site-directed mutagenesis. The modified bases are underlined, for, 
forward primer; rev, reverse primer; Tm, melting temperature (°C), Trip., triple mutant primer. 
Primers Sequences (5' → 3') τm 
H118Afor GGTGATCAACACCAACTACGCCACCGACCGGGCTGGC 83.8 
H118Arev GCCAGCCCGGTCGGTGGCGTAGTTGGTGTTGATCACC 83.8 
H196Afor CGCGGGCCCGGCCGCTACGCCGGACGGC 86.1 
H196Arev GCCGTCCGGCGTAGCGGCCGGGCCCGCG 86.1 
H263Afor GGTGATCGGCGGTGCCGACTCACCGCTGC 80.0 
H263Arev GCAGCGGTGAGTCGGCACCGCCGATCACC 80.0 
D120Afor CAACTACCACACCGCCCGGGCTGGCGG 82.4 
D120Arev CCGCCAGCCCGGGCGGTGTGGTAGTTG 82.4 
D120Tfor CCAACTACCACACCACCCGGGCTGGCGG 78.9 
D120Trev CCGCCAGCCCGGGTGGTGTGGTAGTTGG 78.9 
V67Afor AGAGGACAACTACTACGCGCAGGAAAATTCCATGG 78.9 
V67Arev CCATGGAATTTTCCTGCGCGTAGTAGTTGTCCTCT 78.9 
V67Dfor GGTAGAGGACAACTACTACGACCAGGAAAATTCCATGGTC 78.6 
V67Drev GACCATGGAATTTTCCTGGTCGTAGTAGTTGTCCTCTACC 78.6 
V67lfor GGTAGAGGACAACTACTACATCCAGGAAAATTCCATGGTC 77.6 
V67lrev GACCATGGAATTTTCCTGGATGTAGTAGTTGTCCTCTACC 77.6 
T157Afor GAGATTGTTGCCTTTGCCCGCAAGGGGC 77.8 
T157Arev GCCCCTTGCGGGCAAAGGCAACAATCTC 77.8 
K224Qfor GCAACTGCATTCTCCAGGAGAAGCTGGGC 76.8 
K224Qrev GCCCAGCTTCTCCTGGAGAATGCAGTTGC 76.8 
K226Qfor GCATTCTCAAGGAGCAGCTGGGCAACCTG 78.2 
K226Qrev CAGGTTGCCCAGCTGCTCCTTGAGAATGC 78.2 
Trip.K224Qfor GCGGCTGCATTCTCCAGGAGAAGCTGGGC 81.0 
Trip.K224Qrev GCCCAGCTTCTCCTGGAGAATGCAGCCGC 81.0 
CphAPstla GCGTGCGGGCTGCAGGGATGTCGCTGAC 78.9 
CphAPstlb GTCAGCGACATCCCTGCAGCCCGCACGC 78.9 
 
